Phototherapy and Cryotherapy in Post-exercise Skeletal Muscle Recovery

NCT02622971 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-02-03

No results posted yet for this study

Summary

Volunteers were divided randomly in five experimental groups. VAS (Visual Analogic scale) to measure DOMS (Delayed Onset Muscle Soreness) and blood samples was taken before any procedure. Then, volunteers performed stretching and warm-up followed by MVC test (isometric test in isokinetic dynamometer to measure muscle function). After, volunteers performed the exercise protocol (75 eccentric contractions) to lead to muscle fatigue. Immediately after exercise protocol (1 minute) and 1 hour, 24, 48, 72 and 96 hours after, blood sample, VAS measure and MVC test were repeated. The treatments according to randomisation were performed three minutes after exercise protocol and it were performed again in 24, 48, 72h after eccentric exercise.

The variables regarding to muscle function (MVC, DOMS) and the indirect marker of muscle damage (CK activity) were monitored in all time points mentioned above (baseline, 1 minute, 1 hour, 24, 48, 72 and 96 hours after exercise protocol).

Conditions

  • Post-exercise Muscle Recovery

Interventions

OTHER

PBMT

Effects of phototherapy isolated and/or combined with cryotherapy in post-exercise skeletal muscle recovery.

OTHER

Cryotherapy

Effects of cryotherapy isolated and/or combined with phototherapy in post-exercise skeletal muscle recovery.

Sponsors & Collaborators

  • Multi Radiance Medical

    collaborator INDUSTRY
  • University of Nove de Julho

    lead OTHER

Principal Investigators

  • Ernesto Cesar P Leal-Junior, PhD, PT · University of Nove de Julho

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02622971 on ClinicalTrials.gov